Company / PP&E (Net)
InMed Pharmaceuticals Inc. PP&E (Net) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$992.2K
FY2025
5-year range
$904.3K / $1.2M
FY2022-FY2025
Trend
-20.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $904,252 to $992,199 over the past 3 years.
Based on SEC 10-K filings.
$992,199 in FY2025.
Improved from $904,252 to $992,199 over the past 3 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +3.1%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 20.6% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $992.2K | -20.6% |
| FY2024 | $1.2M | - |
| FY2023 | - | - |
| FY2022 | $904.3K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026